UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 645

Sortiert nach

Contributions of pocket depth and electrostatic interactions to affinity and selectivity of receptors for methylated lysine in water

Organic & biomolecular chemistry, 2015-01, Vol.13 (11), p.3220-3226

2015

Volltextzugriff (PDF)

Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapy

Gut, 2006-11, Vol.55 (11), p.1631-1638

2006

Volltextzugriff (PDF)

Rotterdam score predicts early mortality in Budd‐Chiari syndrome, and surgical shunting prolongs transplant‐free survival

Alimentary pharmacology & therapeutics, 2009-11, Vol.30 (10), p.1060-1069

2009

Volltextzugriff (PDF)

Treating chronic hepatitis C with pegylated interferon alfa‐2a (40 KD) and ribavirin in clinical practice

Alimentary pharmacology & therapeutics, 2006-02, Vol.23 (3), p.397-408

2006

Volltextzugriff (PDF)

12 HIGH SVR12 WITH 16 WEEKS OF TEGOBUVIR AND GS-9256 WITH PEGINTERFERON-ALFA 2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 1 HCV PATIENTS

Journal of hepatology, 2012-04, Vol.56, p.S6-S7

2012

Volltextzugriff (PDF)

Moving inwards, moving outwards, moving upwards: the role of spirituality during the early stages of breast cancer

European journal of cancer care, 2011-09, Vol.20 (5), p.640-652

2011

Volltextzugriff (PDF)

Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo

Hepatology (Baltimore, Md.), 1996-09, Vol.24 (3), p.714-717

1996

Volltextzugriff (PDF)

Clinical trial: exposure to ribavirin predicts EVR and SVR in patients with HCV genotype 1 infection treated with peginterferon alfa‐2a plus ribavirin

Alimentary pharmacology & therapeutics, 2008-07, Vol.28 (1), p.43-50

2008

Volltextzugriff (PDF)

Reverse transcriptase activity in patients with primary biliary cirrhosis and other autoimmune liver disorders

Alimentary Pharmacology and Therapeutics, 2007-08, Vol.26 (4), p.587-595

2007

Volltextzugriff (PDF)

Systematic review: renal and other clinically relevant outcomes in hepatorenal syndrome trials

Alimentary pharmacology & therapeutics, 2007-05, Vol.25 (9), p.1017-1028

2007

Volltextzugriff (PDF)

111 SARCOPENIA PREDICTS EARLY MORTALITY IN PATIENTS WITH CIRRHOSIS

Journal of hepatology, 2011-03, Vol.54, p.S49-S50

2011

Volltextzugriff (PDF)

A compilation of data on European flash floods

Journal of hydrology (Amsterdam), 2009-03, Vol.367 (1), p.70-78

2009

Volltextzugriff (PDF)

Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation

Transplantation, 1996-11, Vol.62 (10), p.1456

1996

Volltextzugriff (PDF)

Exploring differences in response to treatment with peginterferon alpha 2a (40kD) and ribavirin in chronic hepatitis C between genotypes 2 and 3

Journal of viral hepatitis, 2008-01, Vol.15 (1), p.52-57

2008

Volltextzugriff (PDF)

Genotypic succession of mutations of the hepatitis B virus polymerase associated with lamivudine resistance

Journal of hepatology, 2000-09, Vol.33 (3), p.469-475

2000

Volltextzugriff (PDF)

A multicentre study of the usefulness of liver biopsy in hepatitis C

Journal of viral hepatitis, 2004-07, Vol.11 (4), p.375-382

2004

Volltextzugriff (PDF)

Efficacy of interferon treatment for patients with chronic hepatitis C: Comparison of response in cirrhotics, fibrotics, or nonfibrotics

Hepatology (Baltimore, Md.), 1999-07, Vol.30 (1), p.271-276

1999

Volltextzugriff (PDF)

Prevalence of Occult Gastrointestinal Bleeding in Celiac Disease

Clinical gastroenterology and hepatology, 2006-04, Vol.4 (4), p.451-454

2006

Volltextzugriff (PDF)

1042 EFFICACY AND SAFETY RESULTS OF ALBINTERFERON ALFA-2B IN COMBINATION WITH RIBAVIRIN IN INTERFERON-ALFA TREATMENT NAIVE PATIENTS WITH GENOTYPE 2 OR 3 CHRONIC HEPATITIS C

Journal of hepatology, 2009, Vol.50, p.S378-S378

2009

Volltextzugriff (PDF)

819 HEALTH-RELATED QUALITY OF LIFE (HRQOL) WITH ALBINTERFERON ALFA-2B PLUS RIBAVIRIN IN IFN TREATMENT-NAIVE PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C

Journal of hepatology, 2008, Vol.48, p.S306-S307

2008

Volltextzugriff (PDF)

Rapid resolution of chylous ascites after liver transplantation using somatostatin analog and total parenteral nutrition

Transplantation, 1996-05, Vol.61 (9), p.1410

1996

Volltextzugriff (PDF)

High-level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitis

Gastroenterology (New York, N.Y. 1943), 1992-03, Vol.102 (3), p.956-962

1992

Volltextzugriff (PDF)

[615] MANAGEMENT OF CHRONIC HEPATITIS C IN A DIVERSE POPULATION WITH PEGINTERFERON tt-2a AND RIBAVIRIN: FINAL RESULTS OF THE CANADIAN PEGASYS EXPANDED ACCESS PROGRAM (EAP)

Journal of hepatology, 2007, Vol.46, p.S232-S233

2007

Volltextzugriff (PDF)

De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects

Transplantation, 2007-05, Vol.83 (9), p.1162

2007

Volltextzugriff (PDF)

Induction versus noninduction antiviral therapy for chronic hepatitis C virus in patients with congenital coagulation disorders: a Canadian multicentre trial

Canadian journal of gastroenterology, 2007-02, Vol.21 (2), p.91

2007

Volltextzugriff (PDF)

1 – 25 von 645

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(559)
Mit Volltextzugriff
(526)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Hepatology
(13)
Hepatology
(12)
Canadian Journal Of Gastroenterology
(11)
The Lancet
(9)
Leukemia
(8)
Bmj
(7)
British Medical Journal
(7)
Gastrointestinal Endoscopy
(7)
Alimentary Pharmacology & Therapeutics
(6)
American Journal Of Epidemiology
(6)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Contributions of pocket depth and electrostatic interactions to affinity and selectivity of receptors for methylated lysine in water

Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapy

Rotterdam score predicts early mortality in Budd‐Chiari syndrome, and surgical shunting prolongs transplant‐free survival

Treating chronic hepatitis C with pegylated interferon alfa‐2a (40 KD) and ribavirin in clinical practice

12 HIGH SVR12 WITH 16 WEEKS OF TEGOBUVIR AND GS-9256 WITH PEGINTERFERON-ALFA 2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 1 HCV PATIENTS

Moving inwards, moving outwards, moving upwards: the role of spirituality during the early stages of breast cancer

Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo

Clinical trial: exposure to ribavirin predicts EVR and SVR in patients with HCV genotype 1 infection treated with peginterferon alfa‐2a plus ribavirin

Reverse transcriptase activity in patients with primary biliary cirrhosis and other autoimmune liver disorders

Systematic review: renal and other clinically relevant outcomes in hepatorenal syndrome trials

111 SARCOPENIA PREDICTS EARLY MORTALITY IN PATIENTS WITH CIRRHOSIS

A compilation of data on European flash floods

Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation

Exploring differences in response to treatment with peginterferon alpha 2a (40kD) and ribavirin in chronic hepatitis C between genotypes 2 and 3

Genotypic succession of mutations of the hepatitis B virus polymerase associated with lamivudine resistance

A multicentre study of the usefulness of liver biopsy in hepatitis C

Efficacy of interferon treatment for patients with chronic hepatitis C: Comparison of response in cirrhotics, fibrotics, or nonfibrotics

Prevalence of Occult Gastrointestinal Bleeding in Celiac Disease

1042 EFFICACY AND SAFETY RESULTS OF ALBINTERFERON ALFA-2B IN COMBINATION WITH RIBAVIRIN IN INTERFERON-ALFA TREATMENT NAIVE PATIENTS WITH GENOTYPE 2 OR 3 CHRONIC HEPATITIS C

819 HEALTH-RELATED QUALITY OF LIFE (HRQOL) WITH ALBINTERFERON ALFA-2B PLUS RIBAVIRIN IN IFN TREATMENT-NAIVE PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C

Rapid resolution of chylous ascites after liver transplantation using somatostatin analog and total parenteral nutrition

High-level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitis

[615] MANAGEMENT OF CHRONIC HEPATITIS C IN A DIVERSE POPULATION WITH PEGINTERFERON tt-2a AND RIBAVIRIN: FINAL RESULTS OF THE CANADIAN PEGASYS EXPANDED ACCESS PROGRAM (EAP)

De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects

Induction versus noninduction antiviral therapy for chronic hepatitis C virus in patients with congenital coagulation disorders: a Canadian multicentre trial

Suchergebnisse filtern